231 related articles for article (PubMed ID: 27334372)
1. Physiologically based kinetic modeling of the bioactivation of myristicin.
Al-Malahmeh AJ; Al-Ajlouni A; Wesseling S; Soffers AE; Al-Subeihi A; Kiwamoto R; Vervoort J; Rietjens IM
Arch Toxicol; 2017 Feb; 91(2):713-734. PubMed ID: 27334372
[TBL] [Abstract][Full Text] [Related]
2. Physiologically based kinetic models for the alkenylbenzene elemicin in rat and human and possible implications for risk assessment.
van den Berg SJ; Punt A; Soffers AE; Vervoort J; Ngeleja S; Spenkelink B; Rietjens IM
Chem Res Toxicol; 2012 Nov; 25(11):2352-67. PubMed ID: 22992039
[TBL] [Abstract][Full Text] [Related]
3. Mode of action based risk assessment of the botanical food-borne alkenylbenzene apiol from parsley using physiologically based kinetic (PBK) modelling and read-across from safrole.
Alajlouni AM; Al Malahmeh AJ; Kiwamoto R; Wesseling S; Soffers AE; Al-Subeihi AA; Vervoort J; Rietjens IM
Food Chem Toxicol; 2016 Mar; 89():138-50. PubMed ID: 26826679
[TBL] [Abstract][Full Text] [Related]
4. Metabolic Activation of Myristicin and Its Role in Cellular Toxicity.
Zhu X; Wang YK; Yang XN; Xiao XR; Zhang T; Yang XW; Qin HB; Li F
J Agric Food Chem; 2019 Apr; 67(15):4328-4336. PubMed ID: 30912427
[TBL] [Abstract][Full Text] [Related]
5. Toxicological evaluation of myristicin.
Hallström H; Thuvander A
Nat Toxins; 1997; 5(5):186-92. PubMed ID: 9496377
[TBL] [Abstract][Full Text] [Related]
6. Physiologically based biokinetic (PBBK) model for safrole bioactivation and detoxification in rats.
Martati E; Boersma MG; Spenkelink A; Khadka DB; Punt A; Vervoort J; van Bladeren PJ; Rietjens IM
Chem Res Toxicol; 2011 Jun; 24(6):818-34. PubMed ID: 21446753
[TBL] [Abstract][Full Text] [Related]
7. Physiologically based biokinetic (PBBK) modeling of safrole bioactivation and detoxification in humans as compared with rats.
Martati E; Boersma MG; Spenkelink A; Khadka DB; van Bladeren PJ; Rietjens IM; Punt A
Toxicol Sci; 2012 Aug; 128(2):301-16. PubMed ID: 22588462
[TBL] [Abstract][Full Text] [Related]
8. Quantitation of tr-cinnamaldehyde, safrole and myristicin in cola-flavoured soft drinks to improve the assessment of their dietary exposure.
Raffo A; D'Aloise A; Magrì AL; Leclercq C
Food Chem Toxicol; 2013 Sep; 59():626-35. PubMed ID: 23845511
[TBL] [Abstract][Full Text] [Related]
9. Identification and characterization of reactive metabolites in myristicin-mediated mechanism-based inhibition of CYP1A2.
Yang AH; He X; Chen JX; He LN; Jin CH; Wang LL; Zhang FL; An LJ
Chem Biol Interact; 2015 Jul; 237():133-40. PubMed ID: 26091900
[TBL] [Abstract][Full Text] [Related]
10. Abuse of nutmeg (Myristica fragrans Houtt.): studies on the metabolism and the toxicologic detection of its ingredients elemicin, myristicin, and safrole in rat and human urine using gas chromatography/mass spectrometry.
Beyer J; Ehlers D; Maurer HH
Ther Drug Monit; 2006 Aug; 28(4):568-75. PubMed ID: 16885726
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of methyleugenol bioactivation by the herb-based constituent nevadensin and prediction of possible in vivo consequences using physiologically based kinetic modeling.
Al-Subeihi AA; Alhusainy W; Paini A; Punt A; Vervoort J; van Bladeren PJ; Rietjens IM
Food Chem Toxicol; 2013 Sep; 59():564-71. PubMed ID: 23831728
[TBL] [Abstract][Full Text] [Related]
12. A computational study on the biotransformation of alkenylbenzenes by a selection of CYPs: Reflections on their possible bioactivation.
Pedroni L; Louisse J; Dorne JCM; Dall'Asta C; Dellafiora L
Toxicology; 2023 Apr; 488():153471. PubMed ID: 36863505
[TBL] [Abstract][Full Text] [Related]
13. Induction of rat hepatic cytochrome P450 enzymes by myristicin.
Jeong HG; Yun CH
Biochem Biophys Res Commun; 1995 Dec; 217(3):966-71. PubMed ID: 8554622
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of Interindividual Human Variation in Bioactivation and DNA Adduct Formation of Estragole in Liver Predicted by Physiologically Based Kinetic/Dynamic and Monte Carlo Modeling.
Punt A; Paini A; Spenkelink A; Scholz G; Schilter B; van Bladeren PJ; Rietjens IM
Chem Res Toxicol; 2016 Apr; 29(4):659-68. PubMed ID: 26952143
[TBL] [Abstract][Full Text] [Related]
15. In vitro and in vivo metabolism of myristicin in the rat.
Lee HS; Jeong TC; Kim JH
J Chromatogr B Biomed Sci Appl; 1998 Feb; 705(2):367-72. PubMed ID: 9521577
[TBL] [Abstract][Full Text] [Related]
16. Genotoxicity of the alkenylbenzenes alpha- and beta-asarone, myristicin and elimicin as determined by the UDS assay in cultured rat hepatocytes.
Hasheminejad G; Caldwell J
Food Chem Toxicol; 1994 Mar; 32(3):223-31. PubMed ID: 8157216
[TBL] [Abstract][Full Text] [Related]
17. Myristicin-induced neurotoxicity in human neuroblastoma SK-N-SH cells.
Lee BK; Kim JH; Jung JW; Choi JW; Han ES; Lee SH; Ko KH; Ryu JH
Toxicol Lett; 2005 May; 157(1):49-56. PubMed ID: 15795093
[TBL] [Abstract][Full Text] [Related]
18. Genotoxic and apoptotic activities of the food flavourings myristicin and eugenol in AA8 and XRCC1 deficient EM9 cells.
Martins C; Doran C; Laires A; Rueff J; Rodrigues AS
Food Chem Toxicol; 2011 Feb; 49(2):385-92. PubMed ID: 21087650
[TBL] [Abstract][Full Text] [Related]
19. Physiologically based kinetic modeling of bioactivation and detoxification of the alkenylbenzene methyleugenol in human as compared with rat.
Al-Subeihi AA; Spenkelink B; Punt A; Boersma MG; van Bladeren PJ; Rietjens IM
Toxicol Appl Pharmacol; 2012 May; 260(3):271-84. PubMed ID: 22445790
[TBL] [Abstract][Full Text] [Related]
20. Determination of myristicin in commonly spices applying SPE/GC.
Dawidowicz AL; Dybowski MP
Food Chem Toxicol; 2012 Jul; 50(7):2362-7. PubMed ID: 22525861
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]